Effects of Cellular Pathway Disturbances on Misfolded Superoxide Dismutase-1 in Fibroblasts Derived from ALS Patients

• Isil Keskin,

  Affiliation Department of Pharmacology and Clinical Neurosciences, Umeå University, Umeå, Sweden

  ⨯
• Elin Forsgren,

  Affiliation Department of Pharmacology and Clinical Neurosciences, Umeå University, Umeå, Sweden

  ⨯
• Dale J. Lange,

  Affiliation Department of Neurology, Hospital for Special Surgery and Weill Cornell Medical Center, New York, NY, United States of America

  ⨯
• Markus Weber,

  Affiliation Neuromusucular Diseases Unit/ALS Clinic, Kantonsspital St.Gallen, St. Gallen, Switzerland

  ⨯
• Anna Birve,

  Affiliation Department of Pharmacology and Clinical Neurosciences, Umeå University, Umeå, Sweden

  ⨯
• Matthis Synofzik,

  Affiliations Department of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, Tübingen, Germany, German Research Center for Neurodegenerative Diseases (DZNE), University of Tübingen, Tübingen, Germany

  ⨯
• Jonathan D. Gilthorpe,

  Affiliation Department of Pharmacology and Clinical Neurosciences, Umeå University, Umeå, Sweden

  ⨯
• Peter M. Andersen,

  Affiliation Department of Pharmacology and Clinical Neurosciences, Umeå University, Umeå, Sweden

  ⨯
• Stefan L. Marklund

  * E-mail: stefan.marklund@umu.se

  Affiliation Department of Medical Biosciences, Clinical Chemistry, Umeå University, Umeå, Sweden

  ⨯